Table 3 Characteristics of patients from ICU infected with CoNS displaying reduced susceptibility to glycopeptides.
Patient | Age | Diagnosis on admission | Therapy on day of blood cultures | CR-BSI | Catheter removal | Treatment | Micro-biological eradication |
|---|---|---|---|---|---|---|---|
8 | 59 | Pseudomonas aeruginosa pneumonia | piperacillin/tazobactam + claritromicin + teicoplanin | yes | yes | linezolid | yes |
9 | 83 | Abscess of psoas | piperacillin/tazobactam + metronidazole + teicoplanin | ? | no | none | ? |
10 | 53 | Post neurosurgery cerebral abscess | meropenem + teicoplanin | yes | yes | linezolid | yes |
11 | 59 | MDR P. aeruginosa pneumonia | meropenem | ? | no | linezolid | yes |
12 | 85 | Acinetobacter baumannii pneumonia | colimicin | yes | yes | linezolid | yes |
13 | 66 | Sepsis from infected flebitis in multiple trauma patient | fluconazole | yes | yes | linezolid | yes |